0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cholangitis Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-34J5918
Home | Market Reports | Health| Nursing
Global Cholangitis Market Insights Forecast to 2028
BUY CHAPTERS

Global Cholangitis Market Research Report 2024

Code: QYRE-Auto-34J5918
Report
January 2024
Pages:73
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cholangitis Market

Cholangitis is an infection of the biliary tract with the potential to cause significant morbidity and mortality.
The global Cholangitis market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The key factors contributing to the growth of the cholangitis market are the changing lifestyle, increasing awareness of healthcare and geriatric population increase.
This report aims to provide a comprehensive presentation of the global market for Cholangitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cholangitis.

Report Scope

The Cholangitis market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cholangitis market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cholangitis companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Cholangitis Market Report

Report Metric Details
Report Name Cholangitis Market
Segment by Type
  • Acute Cholangitis
  • Primary Sclerosing Cholangitis
  • Secondary Sclerosing Cholangitis
  • Recurrent Pyogenic Cholangitis
Segment by Application
  • Clinical Practise
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Taiho Pharmaceutical, Mayo Clinic, Bayer, Gilead Sciences, RiemserArzneimittel, Zambon
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Cholangitis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Cholangitis Market report?

Ans: The main players in the Cholangitis Market are Taiho Pharmaceutical, Mayo Clinic, Bayer, Gilead Sciences, RiemserArzneimittel, Zambon

What are the Application segmentation covered in the Cholangitis Market report?

Ans: The Applications covered in the Cholangitis Market report are Clinical Practise, Others

What are the Type segmentation covered in the Cholangitis Market report?

Ans: The Types covered in the Cholangitis Market report are Acute Cholangitis, Primary Sclerosing Cholangitis, Secondary Sclerosing Cholangitis, Recurrent Pyogenic Cholangitis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cholangitis Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Acute Cholangitis
1.2.3 Primary Sclerosing Cholangitis
1.2.4 Secondary Sclerosing Cholangitis
1.2.5 Recurrent Pyogenic Cholangitis
1.3 Market by Application
1.3.1 Global Cholangitis Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Practise
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cholangitis Market Perspective (2019-2030)
2.2 Cholangitis Growth Trends by Region
2.2.1 Global Cholangitis Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cholangitis Historic Market Size by Region (2019-2024)
2.2.3 Cholangitis Forecasted Market Size by Region (2025-2030)
2.3 Cholangitis Market Dynamics
2.3.1 Cholangitis Industry Trends
2.3.2 Cholangitis Market Drivers
2.3.3 Cholangitis Market Challenges
2.3.4 Cholangitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cholangitis Players by Revenue
3.1.1 Global Top Cholangitis Players by Revenue (2019-2024)
3.1.2 Global Cholangitis Revenue Market Share by Players (2019-2024)
3.2 Global Cholangitis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cholangitis Revenue
3.4 Global Cholangitis Market Concentration Ratio
3.4.1 Global Cholangitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cholangitis Revenue in 2023
3.5 Cholangitis Key Players Head office and Area Served
3.6 Key Players Cholangitis Product Solution and Service
3.7 Date of Enter into Cholangitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cholangitis Breakdown Data by Type
4.1 Global Cholangitis Historic Market Size by Type (2019-2024)
4.2 Global Cholangitis Forecasted Market Size by Type (2025-2030)
5 Cholangitis Breakdown Data by Application
5.1 Global Cholangitis Historic Market Size by Application (2019-2024)
5.2 Global Cholangitis Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cholangitis Market Size (2019-2030)
6.2 North America Cholangitis Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cholangitis Market Size by Country (2019-2024)
6.4 North America Cholangitis Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cholangitis Market Size (2019-2030)
7.2 Europe Cholangitis Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cholangitis Market Size by Country (2019-2024)
7.4 Europe Cholangitis Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cholangitis Market Size (2019-2030)
8.2 Asia-Pacific Cholangitis Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cholangitis Market Size by Region (2019-2024)
8.4 Asia-Pacific Cholangitis Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cholangitis Market Size (2019-2030)
9.2 Latin America Cholangitis Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cholangitis Market Size by Country (2019-2024)
9.4 Latin America Cholangitis Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cholangitis Market Size (2019-2030)
10.2 Middle East & Africa Cholangitis Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cholangitis Market Size by Country (2019-2024)
10.4 Middle East & Africa Cholangitis Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Taiho Pharmaceutical
11.1.1 Taiho Pharmaceutical Company Detail
11.1.2 Taiho Pharmaceutical Business Overview
11.1.3 Taiho Pharmaceutical Cholangitis Introduction
11.1.4 Taiho Pharmaceutical Revenue in Cholangitis Business (2019-2024)
11.1.5 Taiho Pharmaceutical Recent Development
11.2 Mayo Clinic
11.2.1 Mayo Clinic Company Detail
11.2.2 Mayo Clinic Business Overview
11.2.3 Mayo Clinic Cholangitis Introduction
11.2.4 Mayo Clinic Revenue in Cholangitis Business (2019-2024)
11.2.5 Mayo Clinic Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Cholangitis Introduction
11.3.4 Bayer Revenue in Cholangitis Business (2019-2024)
11.3.5 Bayer Recent Development
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Detail
11.4.2 Gilead Sciences Business Overview
11.4.3 Gilead Sciences Cholangitis Introduction
11.4.4 Gilead Sciences Revenue in Cholangitis Business (2019-2024)
11.4.5 Gilead Sciences Recent Development
11.5 RiemserArzneimittel
11.5.1 RiemserArzneimittel Company Detail
11.5.2 RiemserArzneimittel Business Overview
11.5.3 RiemserArzneimittel Cholangitis Introduction
11.5.4 RiemserArzneimittel Revenue in Cholangitis Business (2019-2024)
11.5.5 RiemserArzneimittel Recent Development
11.6 Zambon
11.6.1 Zambon Company Detail
11.6.2 Zambon Business Overview
11.6.3 Zambon Cholangitis Introduction
11.6.4 Zambon Revenue in Cholangitis Business (2019-2024)
11.6.5 Zambon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Cholangitis Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Acute Cholangitis
    Table 3. Key Players of Primary Sclerosing Cholangitis
    Table 4. Key Players of Secondary Sclerosing Cholangitis
    Table 5. Key Players of Recurrent Pyogenic Cholangitis
    Table 6. Global Cholangitis Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 7. Global Cholangitis Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Cholangitis Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Cholangitis Market Share by Region (2019-2024)
    Table 10. Global Cholangitis Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Cholangitis Market Share by Region (2025-2030)
    Table 12. Cholangitis Market Trends
    Table 13. Cholangitis Market Drivers
    Table 14. Cholangitis Market Challenges
    Table 15. Cholangitis Market Restraints
    Table 16. Global Cholangitis Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Cholangitis Market Share by Players (2019-2024)
    Table 18. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholangitis as of 2023)
    Table 19. Ranking of Global Top Cholangitis Companies by Revenue (US$ Million) in 2023
    Table 20. Global 5 Largest Players Market Share by Cholangitis Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Cholangitis Product Solution and Service
    Table 23. Date of Enter into Cholangitis Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Cholangitis Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Cholangitis Revenue Market Share by Type (2019-2024)
    Table 27. Global Cholangitis Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Cholangitis Revenue Market Share by Type (2025-2030)
    Table 29. Global Cholangitis Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Cholangitis Revenue Market Share by Application (2019-2024)
    Table 31. Global Cholangitis Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Cholangitis Revenue Market Share by Application (2025-2030)
    Table 33. North America Cholangitis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 34. North America Cholangitis Market Size by Country (2019-2024) & (US$ Million)
    Table 35. North America Cholangitis Market Size by Country (2025-2030) & (US$ Million)
    Table 36. Europe Cholangitis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 37. Europe Cholangitis Market Size by Country (2019-2024) & (US$ Million)
    Table 38. Europe Cholangitis Market Size by Country (2025-2030) & (US$ Million)
    Table 39. Asia-Pacific Cholangitis Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 40. Asia-Pacific Cholangitis Market Size by Region (2019-2024) & (US$ Million)
    Table 41. Asia-Pacific Cholangitis Market Size by Region (2025-2030) & (US$ Million)
    Table 42. Latin America Cholangitis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Latin America Cholangitis Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Cholangitis Market Size by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Cholangitis Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Middle East & Africa Cholangitis Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Middle East & Africa Cholangitis Market Size by Country (2025-2030) & (US$ Million)
    Table 48. Taiho Pharmaceutical Company Detail
    Table 49. Taiho Pharmaceutical Business Overview
    Table 50. Taiho Pharmaceutical Cholangitis Product
    Table 51. Taiho Pharmaceutical Revenue in Cholangitis Business (2019-2024) & (US$ Million)
    Table 52. Taiho Pharmaceutical Recent Development
    Table 53. Mayo Clinic Company Detail
    Table 54. Mayo Clinic Business Overview
    Table 55. Mayo Clinic Cholangitis Product
    Table 56. Mayo Clinic Revenue in Cholangitis Business (2019-2024) & (US$ Million)
    Table 57. Mayo Clinic Recent Development
    Table 58. Bayer Company Detail
    Table 59. Bayer Business Overview
    Table 60. Bayer Cholangitis Product
    Table 61. Bayer Revenue in Cholangitis Business (2019-2024) & (US$ Million)
    Table 62. Bayer Recent Development
    Table 63. Gilead Sciences Company Detail
    Table 64. Gilead Sciences Business Overview
    Table 65. Gilead Sciences Cholangitis Product
    Table 66. Gilead Sciences Revenue in Cholangitis Business (2019-2024) & (US$ Million)
    Table 67. Gilead Sciences Recent Development
    Table 68. RiemserArzneimittel Company Detail
    Table 69. RiemserArzneimittel Business Overview
    Table 70. RiemserArzneimittel Cholangitis Product
    Table 71. RiemserArzneimittel Revenue in Cholangitis Business (2019-2024) & (US$ Million)
    Table 72. RiemserArzneimittel Recent Development
    Table 73. Zambon Company Detail
    Table 74. Zambon Business Overview
    Table 75. Zambon Cholangitis Product
    Table 76. Zambon Revenue in Cholangitis Business (2019-2024) & (US$ Million)
    Table 77. Zambon Recent Development
    Table 78. Research Programs/Design for This Report
    Table 79. Key Data Information from Secondary Sources
    Table 80. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cholangitis Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Cholangitis Market Share by Type: 2023 VS 2030
    Figure 3. Acute Cholangitis Features
    Figure 4. Primary Sclerosing Cholangitis Features
    Figure 5. Secondary Sclerosing Cholangitis Features
    Figure 6. Recurrent Pyogenic Cholangitis Features
    Figure 7. Global Cholangitis Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 8. Global Cholangitis Market Share by Application: 2023 VS 2030
    Figure 9. Clinical Practise Case Studies
    Figure 10. Others Case Studies
    Figure 11. Cholangitis Report Years Considered
    Figure 12. Global Cholangitis Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Cholangitis Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Cholangitis Market Share by Region: 2023 VS 2030
    Figure 15. Global Cholangitis Market Share by Players in 2023
    Figure 16. Global Top Cholangitis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cholangitis as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Cholangitis Revenue in 2023
    Figure 18. North America Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Cholangitis Market Share by Country (2019-2030)
    Figure 20. United States Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Cholangitis Market Share by Country (2019-2030)
    Figure 24. Germany Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Cholangitis Market Share by Region (2019-2030)
    Figure 32. China Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Cholangitis Market Share by Country (2019-2030)
    Figure 40. Mexico Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Cholangitis Market Share by Country (2019-2030)
    Figure 44. Turkey Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Cholangitis Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Taiho Pharmaceutical Revenue Growth Rate in Cholangitis Business (2019-2024)
    Figure 47. Mayo Clinic Revenue Growth Rate in Cholangitis Business (2019-2024)
    Figure 48. Bayer Revenue Growth Rate in Cholangitis Business (2019-2024)
    Figure 49. Gilead Sciences Revenue Growth Rate in Cholangitis Business (2019-2024)
    Figure 50. RiemserArzneimittel Revenue Growth Rate in Cholangitis Business (2019-2024)
    Figure 51. Zambon Revenue Growth Rate in Cholangitis Business (2019-2024)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
    Figure 54. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36F5733
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Molecular Diagnosis of Hand, Foot and Mouth Disease Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-4J8612
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Precancer Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-0G6152
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Multi-modal Biometrics in Healthcare Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-27M5604
Tue Feb 20 00:00:00 UTC 2024

Add to Cart